True Wealth Design’s Y-mAbs Therapeutics YMAB Stock Holding History

True Wealth Design’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29	Closed	-$131	–	2905
2025 Q2	$131	Buy	29 +12	+71%	+$54	﹤0.01%	2179
2025 Q1	$76	Buy	+17	New	+$99	﹤0.01%	2288

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

True Wealth Design's YMAB Position: Q3 2025 in Review

True Wealth Design sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 29 shares — an estimated $131 sold.

True Wealth Design first reported a position in YMAB in Q1 2025 and held it in 2 quarters. The position peaked at $131 in Q2 2025. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

True Wealth Design reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
True Wealth Design sold 29 Y-mAbs Therapeutics shares in Q3 2025, an estimated $131.
True Wealth Design first reported a position in Y-mAbs Therapeutics in Q1 2025 and held it in 2 quarters.
True Wealth Design's Y-mAbs Therapeutics position peaked at $131 in Q2 2025.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.